Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/16/2025

Management of Enteric Fever

Diagnosis and Initial Assessment

  • Blood cultures should be collected before starting antibiotics, as they have the highest yield within the first week of symptoms, according to the Journal of Infection 1, 2
  • Stool and urine cultures become positive after the first week of illness, with lower sensitivity than blood cultures, as reported by the Journal of Infection 2
  • Bone marrow cultures have higher sensitivity than blood cultures but are more invasive, as noted by the Journal of Infection 1, 2

Empiric Antibiotic Therapy

  • The American College of Physicians recommends ceftriaxone 50-80 mg/kg/day (maximum 2g/day) IV for 5-7 days for hospitalized patients or severe illness, with treatment continued for 14 days to reduce risk of relapse, as suggested by Praxis Medical Insights 3, 4
  • Azithromycin 20 mg/kg/day (maximum 1g/day) for 7 days is recommended for uncomplicated cases, with azithromycin showing lower risk of clinical failure compared to fluoroquinolones, according to Praxis Medical Insights 3, 4

Important Considerations

  • Over 70% of S. typhi and S. paratyphi isolates imported to the UK are resistant to fluoroquinolones, as reported by the Journal of Infection 1, 2
  • Patients with clinical features of sepsis should receive broad-spectrum antimicrobial therapy immediately after blood culture collection, as recommended by Clinical Infectious Diseases 5, 3

Monitoring and Complications

  • Monitor for complications such as gastrointestinal bleeding, intestinal perforation, and typhoid encephalopathy, which occur in 10-15% of patients, as noted by the Journal of Infection 1, 2
  • Complications are more likely if duration of illness exceeds 2 weeks, as reported by the Journal of Infection 2

Relapse Prevention and Follow-up

  • Relapse rates are lower for ceftriaxone (<8%) and azithromycin (<3%) compared to fluoroquinolones, as reported by the Journal of Infection 2
  • Treatment should be continued for 14 days to reduce risk of relapse, as suggested by the Journal of Infection 2

Common Pitfalls to Avoid

  • Avoid empiric fluoroquinolone use for cases originating from South Asia due to high resistance rates, as recommended by the Journal of Infection and Praxis Medical Insights 2, 4